Independent provider comparison
Updated October 9, 2026
MEDVi vs Wellorithm: Costs, care and treatment fit
A side-by-side look at total cost, medication format, care, commitment and the situations where each option makes more sense.
This content was researched and written with AI assistance. MEDVi referral links are affiliate links: we may earn a commission if you sign up. This is independent information, not medical advice or a clinical review.
The decision
Which should you choose, MEDVi or Wellorithm?
Short answer: The available assessments do not establish a score winner. Compare medication, full cost, care and commitment to decide which fits your needs. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Wellorithm is from $147/mo.
Consider MEDVi if
Users who want both oral and injectable compounded options in one telehealth program.
Consider Wellorithm if
Cash-pay patients who want compounded semaglutide or tirzepatide in a rare oral dissolving tablet format, backed by a 10% weight-loss money-back guarantee and 24/7 support.
Read each assessment label below: missing evidence is not evidence of poor care. Partnership status does not change the score or the factual comparison.
MEDVi
Legacy assessmentThis score comes from an earlier or incomplete assessment. It does not establish that this program is better or worse than another.
Best for users who want both oral and injectable compounded options in one telehealth program.
Visit MEDVi(affiliate link)
Wellorithm
Assessment limitedThis published score has not been reconciled with its recorded evidence. A direct numerical comparison may mislead.
Best for cash-pay patients who want compounded semaglutide or tirzepatide in a rare oral dissolving tablet format, backed by a 10% weight-loss money-back guarantee and 24/7 support.
Visit WellorithmSide by side
MEDVi vs Wellorithm at a glance
Compare the price unit as well as the number. A medication-only price, prepaid monthly equivalent and complete recurring program are not the same thing.
| Feature | MEDVi | Wellorithm |
|---|---|---|
Why each oneMEDViCompounded semaglutide tablets and injections, a separate compounded tirzepatide injection, and brand-name Wegovy and Zepbound paths with a $99 membership plus medication. WellorithmThe combination of compounded GLP-1 in BOTH injectable and oral dissolving tablet formats AND a 10% weight-loss money-back guarantee, a format breadth and outcome-tied refund policy that few compounded-only platforms offer in combination, paired with the trade-off that no founder or legal entity is named on the site. | ||
| Published Assessment | 5.7/10 Legacy assessment | 7.4/10 Assessment limited |
Assessment limitsMEDViThis score comes from an earlier or incomplete assessment. It does not establish that this program is better or worse than another. WellorithmThis published score has not been reconciled with its recorded evidence. A direct numerical comparison may mislead. | ||
| Headline Price | $179 first month, then $299/mo(affiliate link) | from $147/mo |
| Medication Type | Both | Both |
| Insurance Accepted | No | No |
Best ForMEDViUsers who want both oral and injectable compounded options in one telehealth program WellorithmCash-pay patients who want compounded semaglutide or tirzepatide in a rare oral dissolving tablet format, backed by a 10% weight-loss money-back guarantee and 24/7 support | ||
Watch out forMEDViFDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication WellorithmFounding year, corporate ownership and the legal entity behind the program are not published on wellorithm.com; the Terms describe it only as 'a Miami-based company' that connects patients with unnamed 'Professional Entities' (verified 2026-09-03). The site names clinicians and a Miami contact address, but the October 8, 2026 review did not verify which named clinician oversees this GLP-1 program or their program-specific role | ||
| Get started | Visit MEDVi(affiliate link) | Visit Wellorithm |
Trade-offs
Strengths and cautions compared
MEDVi
Pros
- +Compounded semaglutide tablets and injections, plus a separately advertised compounded tirzepatide injection
- +The landing page says the program is HSA and FSA eligible and includes dietician visits and care coaching, with a footnote making that subject to insurance and copay eligibility
- +$179 covers the first month of compounded semaglutide on MEDVi's landing page, including physician review, the personalized plan, medication and free shipping
Cons
- −FDA warning letter #721455, issued February 20, 2026, cites misleading labeling and marketing that implied MEDVi compounded the drugs and that compounded products were equivalent to or FDA-evaluated like approved brands. The letter does not allege unsafe medication
- −Its third-party records conflict: 4.3 out of 5 across 14,680 Trustpilot reviews with 12 percent of them at one star, against an F and no accreditation at the BBB
- −The $179 semaglutide price covers month one only; the FAQ on MEDVi's own landing page says refills are locked in at $299 a month, making the first year $3,468 rather than $2,148
2 more documented cautions
- −Brand-name Wegovy and Zepbound paths add a $99 membership plus a medication cost the page does not publish, and the same page's hero says "No membership or hidden fees!" directly above those cards; availability is subject to change
- −No insurance accepted, and oral compounded semaglutide has less clinical data than injectable forms
Wellorithm
Pros
- +Compounded GLP-1 available in BOTH injectable AND oral dissolving tablet formats, semaglutide and tirzepatide each in two formats, broader format menu than most compounded-only platforms
- +10% weight-loss money-back guarantee: patients who don't lose at least 10% of baseline weight after 16 weeks of medication adherence may be eligible for refund of up to four months of program fees (verified weight documentation required)
- +Competitive entry pricing, $147/mo compounded semaglutide and $249/mo compounded tirzepatide put Wellorithm near the cheaper end of the compounded market
3 more documented strengths
- +Short online eligibility quiz, virtual consultation, 24/7 support availability claimed
- +23,000+ reviews and 4.9-star rating reported (volume is unusually high for this market segment, verify on independent third-party sources before relying on it)
- +Spring promotion advertised at $147 with free shipping included
Cons
- −Founding year, corporate ownership and the legal entity behind the program are not published on wellorithm.com; the Terms describe it only as 'a Miami-based company' that connects patients with unnamed 'Professional Entities' (verified 2026-09-03). The site names clinicians and a Miami contact address, but the October 8, 2026 review did not verify which named clinician oversees this GLP-1 program or their program-specific role
- −49 states only, service is unavailable in Louisiana and outside the United States
- −Billing runs on a 28-day recurring cycle and payments are non-refundable once processed, with no proration for partial months; cancel before your next cycle processes to avoid paying for an unused month
2 more documented cautions
- −The weight-loss guarantee has strict eligibility terms: verified weight documentation (doctor attestation or video evidence), prior medication history disclosure, consistent dosing adherence, and refund processed within 30 days of approval, with only fees actually paid refundable and baseline payments non-refundable; document your starting weight from day one if you plan to rely on it
- −The historical Ozempic and Zepbound pages showed $1,119 in the hero and $1,199 in a pricing card, alongside an internally inconsistent plan footnote. Neither that footnote nor the conflicting prices establishes a valid dose or total bill. Obtain the exact medication, dose, term and upfront charge before paying
Our Verdict
The available assessments do not establish a score winner between MEDVi and Wellorithm. Compare the medication, full cost, care and commitment that fit your needs. An incomplete assessment is not evidence of poor care. Published pricing is not a like-for-like monthly comparison: MEDVi is $179 first month, then $299/mo; Wellorithm is from $147/mo.
Keep narrowing the decision
What should you compare next?
Use the unresolved part of this choice, not a generic related article. These guides own the broader medication, coverage or complete-cost question.
- Pill decisionCompare Wegovy pill prices and accessUse the dedicated guide for dose-specific costs, required memberships and which providers currently list the FDA-approved pill.Continue
- Treatment decisionCompare semaglutide providers and pricesMove from this head-to-head to the broader semaglutide market without confusing compounded products with FDA-approved brands.Continue
- Treatment decisionCompare tirzepatide providers and pricesReview provider options, price units and treatment context across the wider tirzepatide market.Continue
Reviews and pricing sources
Not sure which one is right for you?
Answer a few quick questions and we'll match you to the best GLP-1 provider for your needs. Or keep exploring below.
Still working out whether either one is above board? We check that separately: is MEDVi legit and is Wellorithm legit, with the verification evidence behind each answer.